Where is Accelagen located?

Accelagen is headquartered in Kew East, Australia. It is registered at San Diego, California.

How many employees does Accelagen have?

As of Apr 30, 2026, the latest employee count at Accelagen is 59.

Is Accelagen a funded company?

Accelagen is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Accelagen rank among its competitors?

Accelagen ranks 491st amongst 1712 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of Accelagen?

Accelagen's top competitors include Indegene, IntegriChain and ProPharma Group. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

Accelagen - 2026 Company Profile & Competitors

Accelagen is an unfunded company based in Kew East (Australia), founded in 2007. It operates as a Provider of clinical development and regulatory affairs. Accelagen has not raised any funding yet. The company has 1712 active competitors, including 27 funded and 197 that have exited. Its top competitors include companies like Indegene, IntegriChain and ProPharma Group.

Company Details

Website: www.accelagen.com.au/
Social
Registered Address: San Diego, California

Key Metrics

Founded Year

2007

Location

Kew East, Australia

Stage

Unfunded

Ranked

491^st among 1712 active competitors

Employee Count

59 as on Apr 30, 2026

Similar Companies

ProPharma Group & 441 more

View Accelagen's full profile

Accelagen is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ACCELAGEN INC CIN: 202638681 , United States, Active	Dec 26, 999	-	13 (As on Dec 31, 2024)	-

Accelagen has not raised any funding rounds yet.

Accelagen's employee count trend

Accelagen has 59 employees as of Apr 26. Here is Accelagen's employee count trend over the years:

Uncover Accelagen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Accelagen include Indegene, IntegriChain and ProPharma Group. Here is the list of Top 10 competitors of Accelagen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 17 others	78/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	63/100
3rd	ProPharma Group 2001, Saint Paul (United States), Acquired	Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device	-	Apollo Investment Corporation, Linden & 4 others	61/100
4th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Baird Capital, Intertrust & 8 others	60/100
5th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
6th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
7th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
8th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	56/100
9th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
10th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
491st	Accelagen 2007, Kew East (Australia), Unfunded	Provider of clinical development and regulatory affairs	-	-	23/100